Luma Vision wins expanded FDA nod for its cardiac procedure software

Luma Vision has received expanded FDA clearance for its Verafeye platform, which integrates imaging, visualization, navigation, and guidance into a single AI-driven system for cardiac ablation procedures, enabling real-time anatomy analysis and physician guidance.

This Wire brief sits within Fusion42's coverage of Medtech.